LongerLifeFoundation (@LongerLifeOrg) header
LongerLifeFoundation (@LongerLifeOrg) profile picture

The Longer Life Foundation is a not-for-profit partnership between @RGA_RE and @WUSTLMED that funds research on improving longevity, health, and wellness.

Missouri, USA
Joined November 2015
Combine world-caliber researchers from @WUSTLMed with the risk-underwriting expertise of RGA and the insurance industry. The result? The Longer Life Foundation. Explore the difference we make through a new video series at ow.ly/u6oc50KtCCM
The Longer Life Foundation was founded in 1998 by @RGA_RE and @WUSTLmed with a simple mission: to learn more about human health and longevity and share those discoveries with the world. Hear directly from our investigators about our mission at longerlife.org/
1
1
Strengthening scientific understanding of longevity takes time and investment. Seed money from our non-profit collaboration with @RGA_RE grows into more exciting discoveries, like those from @JHKwonDO @WUSTLmed. Learn more about her #AMR research: youtu.be/YU3qz-alD3M
1
3
A meta-analysis in @TheLancet links a 1°C rise in temperature with increased cardiovascular disease-related mortality and morbidity: ow.ly/JuyA50JN4TN
1
When it comes to long covid, omicron variant risk is reduced from the delta variant, depending on age and time since vaccination: ow.ly/nMp950JN4NB
According to new research at @biomedcentral, four out of five individuals with type II diabetes will develop major adverse renal cardiovascular events over their lifetimes: ow.ly/X1Cs50Inya8
A global age-standardized study @TheLancet shows that thyroid cancer incidence rates were 5x higher in high Human Development Index (HDI) countries than in low and medium HDI countries, but mortality rates were relatively similar: ow.ly/2ls350Iny9O
Is breast cancer overdiagnosed? A new study @bmj_latest of first screening mammograms among US women estimated 15% of detected cancers were indolent precancers or progressive cancers in women who would have died from other causes during their lifetimes: ow.ly/WrTU50Iny9i
Researchers in the Journal Nature investigated UK Biobank brain imaging patients who tested positive for SARS-CoV-2 between two scans, and identified longitudinal brain structural effects: nature.com/articles/s41586-0…
The antiviral drug molnupiravir has reduced the risk of admission to hospital or death by around 50% (from 14% in placebo vs. 7%) in non-hospitalized adults with mild to moderate COVID-19: ow.ly/J2Tb50GwN91